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Background: Niemann-Pick disease (NPD) and Gaucher disease (GD) are well-known lysosomal
storage diseases. Respiratory system involvement is an important cause of morbidity and
mortality in patients with NPD and GD.
Objectives: We tried to assess the clinical, radiological, and histological features of GD and
NPD patients with lung involvement.
Methods: We reviewed medical history, physical examination, radiological, and histological
data of 10 NPD and 7 GD patients.
Results: The most common respiratory symptoms were recurrent lung infection and dys-
pnea. Although lung examination results in 6 NPD patients were normal, they had lung
involvement; 3 patients were diagnosed as NPD directly via lung biopsy during investigation
of recurrent lung infection or interstitial lung disease. All GD patients but 1 had respiratory
system symptoms at the time of diagnosis. Hepatopulmonary syndrome was present in 4 GD
patients. A ground-glass pattern and atelectasis were 2 important high-resolution
computed tomography features in the NPD and GD patients. Flexible bronchoscopy and
bronchoalveolar lavage were used for emergency extraction of bronchial casts in 1 NPD
patient.
Conclusions: Lung involvement in NPD and GD patients should be included in the differen-
tial diagnosis of interstitial lung disease. Besides interstitial appearance on HRCT, atelec-
tasis related to bronchial cast and bronchiectasis are other radiological findings in theseU¨niversitesi, _Ihsan Dogramacı C¸ocuk Hastanesi, Pediatrik Pulmonoloji Departmanı, 06100 Sıhhiye,
, þ90 536 4613759.
.com (B. Gu¨lhan).
2 Elsevier Ltd. All rights reserved.
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Lung involvement in Niemann-Pick disease and Gaucher disease 1279group of patients. Analysis of bronchoalveolar fluid and lung biopsy provide very important
clues for diagnosis. Hepatopulmonary syndrome is an important vascular complication
observed in GD patients.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Lysosomes are intracellular organelles that contain a variety
of hydrolytic enzymes and degrade complex macromole-
cules, including glycosaminoglycans, sphingolipids, glyco-
proteins, and glycogen. Lysosomal storage diseases are
caused by deficiency of one or more of these enzymes. As
a result of such deficiency, the substrate (or substrates)
normally degraded by lysosomes accumulate in various
organs, including the liver, spleen, lungs, and brain.1
Niemann-Pick disease (NPD) is an important lysosomal
storage disorder which is inherited in an autosomal reces-
sive manner and has a frequency of approximately 1 in
100,000 births. Symptoms of NPD are due to the accumu-
lation of lipid-laden macrophages (Niemann-Pick cells) in
such organs as the liver, spleen, bone marrow, brain, and
lungs. NPD has 3 primary variants, based on metabolism and
clinical symptoms. Type A and type B result from inherited
deficiency of sphingomyelinase. Type C is due to defective
cholesterol transport. Lung involvement may be a feature
of NPD; however, the precise incidence is unknown because
the literature consists mostly of small patient series.1
Gaucher disease (GD) is a multisystemic lipidosis, char-
acterized by organomegaly, hematologic problems, and
skeletal involvement. It is an autosomal recessive disease
resulting from deficient activity of a lysosomal enzyme
(glucocerebrosidase). Because of the deficient enzyme
activity glucocerebroside accumulates in macrophages and
the reticuloendothelial system. According to the presence or
absence of neurologic manifestations, 3 clinical subtypes
have been described (types 2-3 and 1, respectively).2 Lung
involvement is not common at presentation and is correlated
with severe forms of the disease. Respiratory problems result
from infiltration of alveolar, interstitial, perivascular, and
peribronchial spaces by lipid-laden macrophages (Gaucher
cells).3 As a complication of chronic liver disease arteriove-
nous shunting (hepatopulmonary syndrome) may also be
observed.4 Patients that are homozygous for 1448G (L444P)
mutation may have an additional risk for lung involvement.5
In order to assess the clinical, radiological, and histo-
logical features of GD and NPD patients with lung involve-
ment, we reviewed medical history, physical examination,
radiological, and histological data of 17 patients (10 NPD, 7
GD) that were followed-up at a tertiary referral clinic in
Turkey.Materials and methods
Patients
The medical files of NPD and GD patients diagnosed
between 1981 and 2010 at Hacettepe University, _IhsanDogramacı Children’s Hospital were reviewed retrospec-
tively. In total, 73 GD and 40 NPD patients were followed
between 1981 and 2010 and a total amount of 23 NPD and
GD patients had lung involvement (20.3%). The study
included 10 NPD and 7 GD patients with lung involvement
who have complete data, as determined based on clinical
features, radiological findings, or bronchoalveolar lavage
(BAL) fluid analysis, that were followed-up by the pediatric
gastroenterology and pulmonology departments. Three
patients were biopsied during the process of investigation
for diffuse parenchymal lung disease and were diagnosed as
NPD-related lipoid pneumonia. Further enzymatic analysis
showed acid sphingomyelinase (ASM) deficiency. On the
other hand, 7 of the NPD patients were previously diag-
nosed as NPD and during follow-up developed symptoms
and signs of accumulation of Niemann-Pick cells in the
lungs. Further radiological investigation and BAL fluid
analysis results proved respiratory system involvement.
Diagnosis of NPD type A and type B was confirmed in each
patient via documentation of reduced ASM activity in iso-
lated leukocytes and/or cultured skin fibroblasts. The
presence or absence of early neurological degeneration led
to differentiation of type A or type B NPD. The diagnosis of
type C NPD was based on abnormal intracellular esterifi-
cation of cholesterol, which is derived from exogenous
lipoprotein-derived cholesterol, measured in cultured
fibroblasts obtained via skin biopsy. Bone marrow aspiration
was performed in all patients and Wright stain was used for
the identification of sea-blue histiocytes before enzymatic
analysis. Bone marrow aspiration was performed in all
patients for identification of Gaucher cells. The diagnosis of
GD was confirmed via documentation of a deficient acid b-
glucosidase level in leukocytes and by mutation analysis.
The presence or absence of neurological findings in the
patients’ histories and physical examination results facili-
tated determination of the subtypes of GD. Seven patients
were diagnosed with GD; 4 had type 1 and 3 had type 3.
Respiratory investigations
Chest X-rays (CXRs), thoracic high-resolution computed
tomography (HRCT), and respiratory function tests were
performed, according to the standard techniques used at
our hospital. All patients had at least 1 CXR during their
follow-up. HRCT was performed in 8 NPD patients and 4 GD
patients (Table 1).
Flexible bronchoscopy and BAL were performed in 4 NPD
patients (2 type C, 1 type A, and 1 type B) by skilled
pediatric pulmonologists. A standard method was used to
collect BAL fluid. In the diagnostic work-up for interstitial
lung disease, surgical lung biopsy was performed in three
patients. Hematoxylin-eosin stain and May-Gru¨nwald
Giemsa stain were used for identification of storage cells.
Table 1 Clinical characteristics of the Niemann-Pick disease patients with lung involvement.
Patients
no.-gender
Type Con Age at
diagnosis
Respiratory findings
at diagnosis
Organs involved HRCT Duration
of follow-up
Mutation Last follow-up
1-F A þ 4.5 mo Recurrent lung infection
PE: Normal
Lung, liver, spleen, CNS ND 2.5 yr GS P189/
GS P189
Deceased
2-F B e 16 mo Isolated dyspnea, recurrent
lung infection,
PE: fine crackles, cyanosis
Lung, liver, spleen GGO 1 yr ND Stable
3-M B þ 11 mo Chronic cough PE: Diminished
lung sounds
prominent on lower lobes
Lung, liver, spleen Bilateral interstitial
infiltration
3 yr ND Stable
4-F B e 18 mo Respiratory failure PE: Cyanotic,
clubbing, fine crackles:
Lung, liver, spleen Widening of pulmonary
arteries/veins in lower
right lung
19.5 yr GS P189/
L187 P
Deceased
5-M B þ 3 mo None PE: Normal Lung, liver, spleen GGO 11 yr L 137P /
L 137P
Stable
6-F B þ 8 yr None PE: Normal Lung, spleen ND 1 yr ND Oxygen support
7-F B þ 9 yr None PE: Normal Lung, liver, spleen Atelectasis in lingula,
bronchiectasis in lingula
and lower lobe of left lung
2 yr ND Stable
8-M B þ 9 yr Dyspnea, productive cough
PE: Tachypnea
Lung, liver, spleen GGO 2 yr ND Stable
9-F C þ 6 yr None PE: Normal Lung, spleen Bilateral reticulonodular
appearance
1 yr ND Stable
10-M C þ 11 mo Recurrent lung infection
PE: Normal
Lung, liver, spleen Atelectasis in upper
right lung
9 mo ND Stable
F: Female; M, Male; Con, Consanguinity; mo, months; yr, year(s); PE, Physical examination of respiratory system; sPO2, Transcutaneous oxygen saturation while breathing room air; GGO,
Ground-glass opacification; CNS, Central nervous system; ND, Not done.
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Lung involvement in Niemann-Pick disease and Gaucher disease 1281To diagnose hepatopulmonary syndrome contrast echocar-
diography was performed in the pediatric cardiology unit.Results
Clinical and radiological data
Niemann-Pick disease
Fourteen patients had lung involvement. In total, 4 patients
were excluded from the study due to incomplete data; 10
NPD patients (4 boys, 6 girls; patients 1e10) with lung
involvement were included in the study. Patients’ clinical
data are summarized in Table 1. Among them, 1 patient was
classified as type A, 7 as type B, and 2 as type C. Age at
diagnosis of NPD ranged between 3 months and 9 years
(median: 17 months). Parental consanguinity was present in
all of the NPD patients, except patient 2 and 4. Six patients
had respiratory complaints at the time NPD was diagnosed.
Respiratory symptoms at diagnosis included isolated dysp-
nea, chronic cough, recurrent lung infections, and respi-
ratory failure. The most common respiratory symptoms
were recurrent lung infection (3 patients) and dyspnea
(2 patients). Patients 1, 2, and 10 suffered from recurrent
lung infections that were responsive to antibiotics. On the
other hand, patients 5, 6, 7, and 9 did not have any signs of
respiratory system involvement at the time of diagnosis,
and did not develop any symptoms during follow-up;
however; radiological evidence was obtained during inves-
tigation of different clinical problems. Respiratory system
examination results in 6 of the NPD patients were normal,
whereas 4 patients had positive findings (Table 1). One of
the symptomatic patients died due to respiratory failure at
the age of 21 years after 19.5 years of follow-up; she was
diagnosed as NPD type B at the age of 1.5 years and her
respiratory problems (cyanosis, clubbing, fine crackles)
began at the age of 12 years. In the present series there was
only one NPD type A patient. She was diagnosed at the age
of 4.5 months following the onset of recurrent lung infec-
tions. BAL was performed to determine the etiology.
Macroscopic examination showed opalescent fluid origi-
nating from all bronchial openings. The most characteristic
finding in the BAL fluid analysis was foamy histiocytes.
Median follow-up period of all NPD patients was 2 years.
Chest X-rays in all but 1 NPD patient (patient 7) exhibi-
ted an interstitial appearance on bilateral lung fields. CXRFigure 1 CXR (a) and HRCin patient 8 showed segmental atelectasis on the left lung.
HRCTwas performed in 8 of the 10 NPD patients (Fig. 1) and
showed predominant ground glass opacification (GGO) in 3
patients. Interestingly, in 2 patients (patients 8 and 10)
HRCT showed atelectasis (Table 1). Patient 4’s CXR
exhibited a bilateral reticulonodular appearance and
elevated left hemidiaphragm, and fluoroscopy showed left
hemidiaphragm paralysis. Thoracic high-resolution
computed tomography was performed in this patient in
order to investigate any possible lung involvement. It
showed thickening of the interlobular septae and axial
interstitium. Additionally, there was widening of the
pulmonary veins, especially in the lower lobes of both
lungs. Echocardiography and catheter angiography
confirmed multiple pulmonary arteriovenous fistulas on the
lower lobes of both lungs and pulmonary hypertension.
Pulmonary artery pressure was 33/12 mmHg (mean:
24 mmHg). Pulmonary function test results of NPD patients
were noted in Table 3. At the time of research, seven
patients were stable whereas one patient was on contin-
uous oxygen support. Two out of ten NPD patients died due
to cardiac and respiratory failure (Table 1).
Gaucher disease
Patients’ clinical data are summarized in Table 2. Nine
children with GD had lung involvement and 2 were excluded
from the study because of incomplete data. In total, 7 GD
patients (4 girls, 3 boys; patients 11e17) with lung
involvement were included in the study. Among them, 4
were born to non-related parents and none received
enzyme replacement therapy. All patients except patient
no.15 had respiratory symptoms at the time of diagnosis.
Patient 15 did not develop any respiratory symptoms during
his follow-up; however, his CXR and HRCT findings indicated
lung involvement (Table 2). Hepatopulmonary syndrome
(HPS) was noted in 4 (patient no. 11, 13, 14, 15) of the 7 GD
patients based on contrast echocardiography. Median
follow-up period of all GD patients was 9 years.
Chest X-rays in all the GD patients showed diffuse
interstitial infiltration in both lung fields. HRCT in 2 GD
patients showed a predominant ground-glass pattern and
superimposed thickening of interlobular septa. Patient 16’s
HRCT showed only focal atelectasis on the lower lobe of the
right lung, whereas patient 13 had normal HRCT findings
(Table 2). Pulmonary function test results of GD patients
were noted in Table 3.T (b) of patient no. 3.
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Table 3 Available pulmonary function test results of
patients with Niemann-Pick disease and Gaucher disease.
Patient
No.
Type FVC
(%pred)
FEV1
(% pred)
FEV1/FVC
(% pred)
3 NPD Type B 83 91 100
4 NPD Type B 40 39 102
6 NPD Type B 76 73 83
8 NPD Type B 104 86 78
13 GD type 1 78 83 107
15 GD type 1 45 45 95
1282 B. Gu¨lhan et al.Overall prognosis of GD patients were worse than NPD
patients, three patients were on continuous oxygen
support. Unfortunately, four patients died due to cardiac
and respiratory failure (Table 2). None of the patients
received enzyme replacement therapy.
Bronchoalveolar lavage analysis
Flexible bronchoscopy and BAL were performed in 4 NPD
patients (patients 1, 8, 9, and 10) and 2 GD patients
(patients 16 and 17). Lipid-laden macrophages were shown
in all patients who underwent bronchoscopy. Flexible
bronchoscopy was performed in patient 8 initially to
diagnose lung involvement. When he developed acute
severe respiratory failure, CXR showed total atelectasis
(Fig. 2) and he underwent emergency bronchoscopy.
Bronchial cast formation was observed in the right bron-
chus (Fig. 3) and after removal of the casts via gentle
aspiration and whole-lung lavage the patient’s symptoms
resolved. Follow-up CXRs (Fig. 2) showed resolution of
atelectasis.
Histological analysis
In all, 3 patients were diagnosed as NPD directly via lung
biopsy during investigation of recurrent lung infection or
interstitial lung disease. Patients 2 and 8 suffered from
recurrent “lung infections” that began at 4 and 12 months
of age, respectively. They were both hospitalized several
times and routine etiologic investigation did not reveal
any possible cause. Patient no. 2 did not accept flexible
bronchoscopy and lung biopsy was performed. On flexible
bronchoscopy of patient no. 8, bronchial casts were
extracted from both lungs. And lung biopsy was performed
for etiological purposes. Microscopic examination showed
foamy histiocytes in the alveolar spaces and interstitial
tissue (Fig. 4). Interstitial fibrosis was not observed; there
were only scattered lymphocytes.
Patient 6 was an eight-year-old girl was admitted to our
center for evaluation of a diffuse reticulo-nodular
appearance of both lungs on CXR. She had been under-
weight since infancy. Her spleen was palpabl 8 cm below
the costal margin. The liver was not palpated. The
neurological examination was normal. Routine investiga-
tion did not reveal any etiological cause. Because of the
fact that flexible bronchoscopy was not available at that
time, an open lung biopsy was performed due to the
Figure 2 CXR of patient 8 before (a) and after (b) Bronchoscopy.
Lung involvement in Niemann-Pick disease and Gaucher disease 1283suspicion of miliary tuberculosis. Microscopic examination
showed nodular clusters of oil-red O- and Sudan-black B-
positive foamy histiocytes in the alveoli, located primarily
in the perivascular, peribronchial, and subpleural regions. A
Wright-stained bone marrow specimen showed many foamy
histiocytes.
Discussion
The present study aimed to assess the clinical, radiological,
and histological features of NPD and GD patients diagnosed
at a referral center in Turkey. Lung involvement was
reported in all types of NPD, including type A. A recent
study that included 10 infants with type A NPD reported the
onset of respiratory system involvement at a median age of
9 months.6 Similarly, another case series of 13 patients
reported that only 1 patient was diagnosed as type A NPD.1
In our series, there was only one NPD type A patient. She
died at the age of 3 years due to severe respiratory
insufficiency.
In contrast to type A, type B NPD has a more variable
course. Lung involvement is typically asymptomatic and isFigure 3 Extracted bronchial cast of patient 8.observed primarily in adult patients following evaluation of
mild respiratory system complaints.7e10 Respiratory system
involvement in such patients is variable; some patients
exhibit mild respiratory symptoms such as recurrent
cough11; however, severe and fatal lung disease is also
reported. In series of McGovern et al., shortness of breath
and pulmonary infections are two frequent symptoms (42%
each). And 20% of the patients had respiratory disease at
presentation.12 Lung involvement is also detected during
evaluation of respiratory symptoms, such as dyspnea,
chronic cough, and recurrent lung infections. In the present
study 7 type B NPD patients had lung involvement; 3
patients were completely asymptomatic with normal lung
examination results; however, during follow-up they
developed radiological or histological signs of lung
involvement. Respiratory function tests of our patients
were normal or restrictive.
Guillemot et al. reported 13 NPD patients with lung
involvement and two of them were type C NPD.1 They both
had severe neurological involvement and developedFigure 4 Foamy histiocytes in the alveoli and interstitial
tissue (hematoxylin-eosin, original magnification 100).
1284 B. Gu¨lhan et al.pulmonary symptoms within the first months of life that
progressed to severe respiratory failure before the age of 3
years. One of these patients died at the age of 3 years and
the other was lost to follow-up. In the present study there
were 2 type C NPD patients; one did not have any respira-
tory system complaints or findings at the time of diagnosis,
only radiological evidence, whereas the other presented
with recurrent lung infections. At the last follow-up they
were both stable, although their follow-up was relatively
short (9 months and 1 year). Although recurrent lung
infections are described for all of the NPD types, alterations
of the immune responses are more abundant in type C
disease.13
Two treatment modalities have been described for lung
involvement in NPD patients. Bone marrow transplantation
was reported to be successful in decreasing pulmonary
infiltrates.14 Whole lung lavage was also reported to be an
effective treatment, especially in adults15,16; however,
results in children differ. Uyan et al. reported a 3-month-
old girl diagnosed as type B NPD with lung involvement.17
Unilateral lung lavage was performed; however, she did
not improve clinically or radiologically, and died at the age
of 15 months. There are no data about enzyme replace-
ment therapy or substrate reduction therapy for patients
with lung involvement of NPD and none of our patients
received any of them.
In the present study BAL was performed in NPD patients
for diagnostic (patients 1, 8, 9, and 10) and therapeutic
purposes (patient 8). An advantage of BAL is the avoidance
of performing lung biopsy for determining lung involve-
ment. Three out of ten NPD patients underwent lung
biopsy. All biopsy procedures were performed for the
differential diagnosis of recurrent lung infection or due to
a reticulonodular pattern on CXR.
Chest X-ray and CT scans are not specific for the diag-
nosis of lung involvement in NPD and GD patients. Men-
delson et al. investigated the CXR and thin-section CT
features of 53 NPD patients with lung involvement.18
Evidence of interstitial lung disease (interstitial thick-
ening and ground-glass appearance) was commonly
observed with thin-section CT scans. In the present study
the most common CT abnormality was ground-glass
appearance. Patients 7 and 10 had atelectasis on HRCT.
More interestingly, patient 7 also had bronchiectasis in the
lingula and left lower lobe. Bronchoscopy showed a white
mucous plug that was prominent in the left upper lobe and
lingula. To the best of our knowledge this is the first report
of an NPD patient with bronchiectasis. A study performed
with ASM-deficient mice reported continuous pulmonary
inflammation and increased cellular infiltrates, which
resulted in alteration in surfactant composition. Abnormal
surfactant and inflammation contribute to lung abnormali-
ties,19,20 which we think may have been the cause of
bronchiectasis in our patient.
In the present study there were 7 GD patients; 3 with
neurological involvement and 1 (patient 15) without any
respiratory system complaints and normal physical exami-
nation results, whose HRCT showed GGO and interlobular
septal thickening.
Santamaria et al. suggested that patients with GD that
are homozygous for the L444P mutation might have an
increased risk for lung involvement.5 In the present study 3patients with type 3 GD were homozygous for L444P. On the
other hand, 3 GD patients were heterozygous for N370S,
which is a predictive mutation for type 1 disease, and 1
patient was compound heterozygous for N370S/L444P.
Emre et al.21 reported that the most prevalent glucocere-
brosidase mutations in Turkish patients were L444P and
N370S, which is consistent with the present study’s findings.
More than 50% of GD patients die due to respiratory failure,
and the remainder require continuous oxygen support. In
addition, all of the present study’s patients that were
homozygous for L444P died due to respiratory failure.
As a serious complication of long-standing liver disease
in GD patients, arteriovenous shunting can also be
observed.4,22 Hepatopulmonary syndrome is associated
with severe hypoxemia in the setting of hepatic dysfunction
and intrapulmonary vascular dilatation. This dilatation is
the one of the major features of hepatopulmonary
syndrome and is the main cause of hypoxemia in such
patients. This dilatation is thought to be a result of failure
of the liver to clear circulating pulmonary vasodilators and
inhibition of circulating vasoconstrictive substances.4 In the
present study contrast echocardiography showed that 4 of
the 7 GD patients had hepatopulmonary syndrome. It is an
important vascular complication of GD and may contribute
to the worse prognosis of lung involvement in GD patients in
our series. None of our patients received enzyme replace-
ment therapy or substrate reduction therapy. Goitein et al.
reported their experience of enzyme therapy in lung
involvement of GD and pointed out the heterogeneity in
response to this type of treatment.2 Schiffmann et al.
reported an improvement in pulmonary function test
results in GD type 3 patients receiving substrate reduction
therapy (miglustat) in addition to enzyme replacement
therapy.23
The present study’s limitation is its retrospective design;
however, the findings show that both NPD and GD can cause
important respiratory system signs and symptoms, both at
diagnosis and during follow-up. Lung involvement in patients
with NPD and GD should be included in the differential
diagnosis of interstitial lung disease; lung biopsy provides
very important diagnostic clues. Microscopic analysis of BAL
fluid is another diagnostic tool and may show foamy macro-
phages, which are not pathognomonic but suggestive of NPD
and Gaucher cells, indicating GD. Bronchial casts can be
observed as a feature of NPD and may cause significant
respiratory distress and extraction of bronchial casts and
whole-lung lavage facilitate clinical and radiological
improvement in suchpatients.Overall prognosiswasworse in
the GD patients; however, this might have been due to the
NPD patients’ shorter follow-up period.
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